Systane Balance Emulsion
Pricing Report NDC 0065-1433-02

Current NADAC: $1.16863 per ML · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Systane Balance (NDC 0065-1433-02) is $1.16863 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human over the counter drug provided by Alcon Laboratories, Inc., this medication is distributed in a 1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.16863
Per ML

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.70509 to $1.16887 per ML. Over this 13 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.7051 - $1.1689
Market Volatility
65.78% Variance
Latest Trend
0.02%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $1.16863 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 19, 2026 $1.00097 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jul 22, 2026 $1.16887 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jul 22, 2026 $0.98741 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 17, 2026 $1.16679 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 17, 2026 $0.98551 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2026 $1.16714 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2026 $0.98209 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Apr 22, 2026 $1.16719 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Apr 22, 2026 $0.98129 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 18, 2026 $1.16620 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 18, 2026 $0.97940 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026